Two Sigma Securities’s Oruka Therapeutics ORKA Stock Holding History

Two Sigma Securities’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,010	Closed	-$20.6K	–	3775
2023 Q4	$20.6K	Buy	+1,010	New	+$22.7K	﹤0.01%	2721
2022 Q3	–	Sell	-853	Closed	-$25K	–	3203
2022 Q2	$25K	Buy	+853	New	+$24.1K	﹤0.01%	1931
2019 Q2	–	Sell	-58	Closed	-$5K	–	2487
2019 Q1	$5K	Buy	+58	New	+$5.15K	﹤0.01%	1748
2018 Q2	–	Sell	-150	Closed	-$16K	–	3076
2018 Q1	$16K	Buy	+150	New	+$40.3K	﹤0.01%	2589

Other funds holding ORKA

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Two Sigma Securities's ORKA Position: Q1 2024 in Review

Two Sigma Securities sold out of Oruka Therapeutics (ORKA) in Q1 2024, closing a stake of 1,010 shares — an estimated $20.6K sold.

Two Sigma Securities first reported a position in ORKA in Q1 2018 and held it in 4 quarters. The position peaked at $25K in Q2 2022. 22 funds tracked by Wall St. Rank hold ORKA as of Q1 2024.

Two Sigma Securities reported no remaining Oruka Therapeutics position as of Q1 2024 after selling out during the quarter.
Two Sigma Securities sold 1,010 Oruka Therapeutics shares in Q1 2024, an estimated $20.6K.
Two Sigma Securities first reported a position in Oruka Therapeutics in Q1 2018 and held it in 4 quarters.
Two Sigma Securities's Oruka Therapeutics position peaked at $25K in Q2 2022.
22 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.